Ellen O'Connor Vos - 09 Jul 2024 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Jul 2024, 16:31:41 UTC
Prior SEC filing
02 Jul 2024
Next SEC filing
13 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Ellen Vos

Key filing fact

Ellen O'Connor Vos filed Form 4 for Aspira Women's Health Inc. (AWHL) on 10 Jul 2024.

Key facts

  • This page summarizes Ellen O'Connor Vos's Form 4 filing for Aspira Women's Health Inc. (AWHL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Jul 2024, 16:31.

Change

  • Previous filing in this sequence was filed on 02 Jul 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AWH transaction

Common Stock

Award

Transaction value
Shares
+3,268
Change %
+9.9%
Price
Shares after
36,146
Date
09 Jul 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AWH transaction Derivative

Warrant (Right to buy)

Award

Transaction value
Shares
+3,268
Change %
Price
Shares after
3,268
Date
09 Jul 2024
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
3,268
Exercise price
$2.25
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .